Compare AIHS & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AIHS | XAIR |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7M | 5.4M |
| IPO Year | 2017 | 2015 |
| Metric | AIHS | XAIR |
|---|---|---|
| Price | $1.12 | $0.53 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 12.8K | ★ 352.2K |
| Earning Date | 02-13-2026 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 14.63 | ★ 62.09 |
| EPS | ★ N/A | N/A |
| Revenue | $3,389,072.00 | ★ $3,705,000.00 |
| Revenue This Year | N/A | $122.00 |
| Revenue Next Year | N/A | $58.15 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 219.67 |
| 52 Week Low | $0.25 | $0.15 |
| 52 Week High | $8.26 | $3.78 |
| Indicator | AIHS | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 38.44 | 42.35 |
| Support Level | $1.12 | $0.45 |
| Resistance Level | $1.28 | $0.60 |
| Average True Range (ATR) | 0.08 | 0.05 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 25.00 | 59.10 |
Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with lease term no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.